Back
Trulieve Cannabis Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
17
TCNNF
Trulieve Cannabis
Last Price:
5.96
Seasonality Move:
12.73%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
30.75
Seasonality Move:
16.11%
Sell
17
Trulieve Cannabis (TCNNF)
is a Sell
Is Trulieve Cannabis a Buy, Sell or Hold?
- The current Trulieve Cannabis [TCNNF] share price is $6.12. The Score for TCNNF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- TCNNF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $27.75. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCNNF Stock Price Chart
What is Trulieve Cannabis's stock price today?
-
The Trulieve Cannabis share price today is $6.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCNNF is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $27.75
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
TCNNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.5 | Sell |
Relative Strength Index (14 RSI): | 31.44 | Sell |
Chaikin Money Flow: | -172125 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.68 - 12.68) | Sell |
Bollinger Bands (100): | (8.46 - 12.04) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 47.09 | Sell |
Chaikin Money Flow: | 727660 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.94 - 28.86) | Sell |
Bollinger Bands (100): | (28.59 - 38.65) | Sell |
TCNNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.5 | Sell |
20-day SMA: | 8.86 | Sell |
50-day SMA: | 10.69 | Sell |
200-day SMA: | 10.39 | Sell |
8-day EMA: | 6.69 | Sell |
20-day EMA: | 8.23 | Sell |
50-day EMA: | 9.7 | Sell |
200-day EMA: | 9.75 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.78 | Sell |
20-day SMA: | 28.02 | Sell |
50-day SMA: | 29.23 | Sell |
200-day SMA: | 42.54 | Sell |
8-day EMA: | 27.83 | Sell |
20-day EMA: | 28.09 | Sell |
50-day EMA: | 29.85 | Sell |
200-day EMA: | 39.55 | Sell |
Trulieve Cannabis Earnings Growth & TCNNF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.10 per share, and an increase next year of $0.47 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
Trulieve Cannabis Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |